Is hepatitis B immunoglobulin necessary in prophylaxis of hepatitis B recurrence after liver transplantation? A meta-analysis

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Wang, Peijie ^a,b   Tam, Ngalei ^a,c   Wang, Haochen ^a   Zheng, Huanwei ^d,e   Chen, Philip ^e   Wu, Linwei ^a   He, Xiaoshun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c THE UNIVERSITY OF HONG KONG SHENZHEN HOSPITAL   (China)

^d Shijiazhuang Fifth Hospital   (China)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; EMTRICITABINE; HEPATITIS B ANTIBODY; LAMIVUDINE; TENOFOVIR DISOPROXIL; VIRUS DNA; HEPATITIS B HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN;

ARTICLE; COMBINATION CHEMOTHERAPY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER TRANSPLANTATION; META ANALYSIS; NONHUMAN; RECURRENT DISEASE; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VIRUS MUTANT; BLOOD; GENETICS; MUTATION;

DNA, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULINS; LIVER TRANSPLANTATION; MUTATION; RECURRENCE;

EID: 84905472523     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104480     Document Type: Article

References (41)

1. Lai CL, Ratziu V, Yuen MF, Poynard T (2003) Viral hepatitis B. Lancet 362: 2089-2094. (Pubitemid 38032767)
2. Popescu I, Ionescu M, Brasoveanu V, Hrehoret D, Matei E, et al. (2010) [Liver transplantation-indications, surgical technique, results-the analysis of a clinical series of 200 cases]. Chirurgia (Bucur) 105: 177-186.
3. Freeman RB, Sanchez H, Lewis WD, Sherburne B, Dzik WH, et al. (1991) Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation. Transplantation 51: 793-797.
4. O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, et al. (1992) Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 14: 104-111.
5. Samuel D (2009) The option of liver transplantation for hepatitis B: where are we? Dig Liver Dis 41 Suppl 2: S185-S189.
6. Starzl TE, Demetris AJ, Van Thiel D (1989) Liver transplantation (1). N Engl J Med 321: 1014-1022.
7. Lo CM, Fan ST, Liu CL, Lai CL, Wong J (2003) Prophylaxis and treatment of recurrent hepatitis B after liver transplantation. Transplantation 75: S41-S44.
8. Saab S, Kim M, Wright TL, Han SH, Martin P, et al. (2000) Successful orthotopic liver transplantation for lamivudine-associated YMDD mutant hepatitis B virus. Gastroenterology 119: 1382-1384.
9. Yang Y, Yang Y, Zhang J, Yi HM, Lu MQ, et al. (2008) [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients]. Nan Fang Yi Ke Da Xue Xue Bao 28: 1810-1812.
10. Honaker MR, Shokouh-Amiri MH, Vera SR, Alloway RR, Grewal HP, et al. (2002) Evolving experience of hepatitis B virus prophylaxis in liver transplantation. Transpl Infect Dis 4: 137-143. (Pubitemid 35364777)
11. Brock GN, Mostajabi F, Ferguson N, Carrubba CJ, Eng M, et al. (2011) Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage? Transpl Int 24: 570-581.
12. Freshwater DA, Dudley T, Cane P, Mutimer DJ (2008) Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study. Transplantation 85: 1105-1111. (Pubitemid 351590187)
13. Rao W, Wu X, Xiu D (2009) Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis. Transpl Int 22: 387-394.
14. Yamamoto M, Little G, Imagawa DK (2009) Hepatitis B immunoglobulin in preventing reinfection following liver transplantation. Expert Rev Anti Infect Ther 7: 321-328.
15. Fung J, Cheung C, Chan SC, Yuen MF, Chok KS, et al. (2011) Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation. Gastroenterology 141: 1212-1219.
16. Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, et al. (1996) Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 348: 1212-1215. (Pubitemid 26361609)
17. Perrillo R (1999) Multicenter studies of Lamivudine for the treatment and prevention of hepatitis B after liver transplantation. Ochsner J 1: 33-36.
18. Wesdorp DJ, Knoester M, Braat AE, Coenraad MJ, Vossen AC, et al. (2013) Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective. J Clin Virol 58: 67-73.
19. Fung J, Chan SC, Cheung C, Yuen MF, Chok KS, et al. (2013) Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B. Am J Gastroenterol 108: 942-948.
20. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, et al. (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73: 712-716. (Pubitemid 37267119)
21. Buti M, Mas A, Prieto M, Casafont F, Gonzalez A, et al. (2007) Adherence to Lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hepatitis B virus recurrence. Transplantation 84: 650-654. (Pubitemid 47429048)
22. Yuan CH, Xiu DR, Jiang B, Li ZF, Li L, et al. (2013) HBV recurrence lowered by lamivudine/HBIG combination therapy in liver transplant patients: ten-year experience. Hepatobiliary Pancreat Dis Int 12: 149-153.
23. Lo CM, Liu CL, Lau GK, Chan SC, Ng IO, et al. (2005) Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine. Liver Transpl 11: 807-813. (Pubitemid 40975583)
24. Dai J, Lu S, Yan L, Li B, Lai W, et al. (2009) [Long-term prevention of virus recurrence among recipients with HBV active replication following liver transplantation]. CHINESE JOURNAL OF HEPATOBILIARY SURGERY 15: 106-109.
25. Anselmo DM, Ghobrial RM, Jung LC, Weaver M, Cao C, et al. (2002) New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann Surg 235: 611-619, 619-620.
26. Teperman LW, Poordad F, Bzowej N, Martin P, Pungpapong S, et al. (2013) Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation. Liver Transpl 19: 594-601.
27. Yi MA, Qiang T, Xiao-shun HE, Guo-dong W, An-bin HU (2009) Prevention and management of hepatitis B virus reinfection after liver transplantation. CHINESE JOURNAL OF SURGERY 47: 1209-1212.
28. Angus PW, Patterson SJ, Strasser SI, McCaughan GW, Gane E (2008) A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis. Hepatology 48: 1460-1466.
29. Zheng S, Chen Y, Liang T, Lu A, Wang W, et al. (2006) Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis. Liver Transpl 12: 253-258. (Pubitemid 43273784)
30. Jie X, Zhan-yu Y, Jia C, Rui L, Nan Z, et al. (2007) [Prevention and treatment of HBV reinfection after liver transplantation]. CHINESE JOURNAL OF DIGESTIVE SURGERY 6: 348-351.
31. Xia N, Fu Z, Qiu B, Wang Z, Li X, et al. (2006) [Low-dose intra-muscular hepatitis B immunoglobulin combined with lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation]. WORLD CHINESE JOURNAL OF DIGESTOLOGY 14: 1288-1293.
32. Qiang X, Zhi-hai P, Jun L, Shu-yun W, Guo-qing C, et al. (2004) [Low-dose hepatitis B immunoglobulin with Lamivudine in prophylaxis of hepatitis B recurrence after liver transplantation]. CHINESE JOURNAL OF ORGAN TRANSPLANTATION 25: 53.
33. Yoshida H, Kato T, Levi DM, Regev A, Madariaga JR, et al. (2007) Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection. Clin Transplant 21: 166-171. (Pubitemid 46505722)
34. Yuan G, Duan Y,Wang F, Liang SS, Zhu L (2002) [Prevention and treatment of HBV reinfection following liver transplantation]. Zhonghua Gan Zang Bing Za Zhi 10: 14-16.
35. Jiao ZY, Jiao Z (2007) Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen. Transplant Proc 39: 1533-1536.
36. Zhu JP, Zhang TL, Li L, Yuan J, Song SB, et al. (2003) Prevention and treatment of hepatitis B recurrence after liver transplantation. Hepatobiliary Pancreat Dis Int 2: 500-503. (Pubitemid 37441665)
37. Schiff E, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, et al. (2007) Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results. Liver Transpl 13: 349-360. (Pubitemid 46444463)
38. Neff GW, O'Brien CB, Nery J, Shire N, Montalbano M, et al. (2004) Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade. Liver Transpl 10: 1372-1378. (Pubitemid 39530052)
39. Saab S, Waterman B, Chi AC, Tong MJ (2010) Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review. Liver Transpl 16: 300-307.
40. Wong TC, Fung JY, Lo CM (2013) Prevention of recurrent hepatitis B infection after liver transplantation. Hepatobiliary Pancreat Dis Int 12: 465-472.
41. Cholongitas E, Vasiliadis T, Antoniadis N, Goulis I, Papanikolaou V, et al. (2012) Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation. Transpl Infect Dis 14: 479-487.